Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 11.83
+0.01 (0.08%)
At close: Dec 19, 2025
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 4.01 billion as of December 19, 2025. Its market cap has decreased by -51.73% in one year.
Market Cap
4.01B
Enterprise Value
4.33B
Revenue
1.01B
Ranking
n/a
PE Ratio
181.89
Stock Price
11.83
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 4.01B, an increase of 2,535.77%. That is a compound annual growth rate of 49.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 4.01B | -51.36% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | 1.06B | 169.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 83.93B |
| Pro Medicus | 22.79B |
| Cochlear | 16.89B |
| Sonic Healthcare | 11.13B |
| Ramsay Health Care | 7.84B |
| Ansell | 4.97B |
| Mesoblast | 3.71B |
| Neuren Pharmaceuticals | 2.46B |